CNSP
Cns Pharmaceuticals Inc

7,819
Mkt Cap
$4.63M
Volume
29,036.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.04
CNSP Fundamentals
Price
$8.05
Prev Close
$8.59
Open
$8.26
50D MA
$7.91
Beta
0.73
Avg. Volume
45,790.48
EPS (Annual)
-$466.44
P/B
0.31
Rev/Employee
$0.00
Loading...
Loading...
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Cns Pharmaceuticals Inc?
What is the 52-week high for Cns Pharmaceuticals Inc?
What is the 52-week low for Cns Pharmaceuticals Inc?
What is Cns Pharmaceuticals Inc stock price today?
What was Cns Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Cns Pharmaceuticals Inc?
What is the Price-to-Book ratio of Cns Pharmaceuticals Inc?
What is the 50-day moving average of Cns Pharmaceuticals Inc?
How many employess does Cns Pharmaceuticals Inc has?

Latest CNSP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.